Experiment 1304095

Worktypes

CLINICAL STUDIES

Alerts

A STANDARDIZED EXTRACT WAS USED IN THIS STUDYSEE ARTICLE FOR OTHER TEST RESULTS.

Details

PropertyValue
Pharmacology
ANTIDEMENTIA ACTIVITY
Administration routeORAL
OrganismGinkgo biloba (GINKGOACEAE)
CitationIHL,R: TRIBANEK,M: BACHINSKAYA,N:. (2010). BASELINE NEUROPSYCHIATRIC SYMPTOMS ARE EFFECT MODIFIERS IN GINKGO BILOBA EXTRACT (EGB 761) TREATMENT OF DEMENTIA WITH NEUROPSYCHIATRIC FEATURES. RETROSPECTIVE DATA ANALYSES OF A RANDOMIZED CONTROLLED TRIAL. 299(1-2)
Amount utilized
Compound isolated
Dose amount240 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES